# Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers

> **NCT02548806** · PHASE1 · COMPLETED · sponsor: **Valerio Therapeutics** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clonidine MBT 50µg
- **DRUG:** Clonidine MBT 100µg
- **DRUG:** Catapres 100μg

## Key facts

- **NCT ID:** NCT02548806
- **Lead sponsor:** Valerio Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-04
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02548806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02548806, "Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02548806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*